Omega Q4 adjusted FFO $0.73 vs $0.77 YoY; Nareit FFO turns negative

OMEGA HEALTHCARE INVESTORS INC

2022-FY EPS reported $1.80 revenue$878,244,000

Q4 net income $47M ($0.19/sh) vs $34M ($0.14) a year ago.
Nareit FFO loss of $30M ($0.13/sh) vs $124M ($0.50) in Q4 2021.
Adjusted FFO $177M ($0.73/sh) vs $190M ($0.77); FAD $171M vs $179M.
Completed $103M in new investments; sold 33 facilities for $321M cash, gain $180M.
Dividend maintained at $0.67/share quarterly; full-year AFFO $2.99 vs $3.31.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

OMEGA HEALTHCARE INVESTORS INC reported the year ended December 31, 2022 results: net income $439 million, or $1.80 per common share, EPS $1.80 per common share.

Period: the year ended December 31, 2022
Net income: $439 million, or $1.80 per common share
EPS: $1.80 per common share
Result: reported results

Exact text from the filing

Net income for the year of $439 million, or $1.80 per common share, compared to $428 million, or $1.75 per common share, for the same period in 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

OMEGA HEALTHCARE INVESTORS INC reported the quarter ended December 31, 2022 results: net income $47 million, or $0.19 per common share, EPS $0.19 per common share.

Period: the quarter ended December 31, 2022
Net income: $47 million, or $0.19 per common share
EPS: $0.19 per common share
Result: reported results

Exact text from the filing

Net income for the quarter of $47 million, or $0.19 per common share, compared to $34 million, or $0.14 per common share, for the same period in 2021.

View on SEC.gov

Browse all earnings releases →

OMEGA HEALTHCARE INVESTORS INC filing history →

Source: SEC EDGAR

accession 0000888491-23-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.